WO2025136342 - TABLETS COMPRISING BREXPIPRAZOLE
National phase entry is expected:
Publication Number
WO/2025/136342
Publication Date
26.06.2025
International Application No.
PCT/TR2024/051659
International Filing Date
20.12.2024
Title **
[English]
TABLETS COMPRISING BREXPIPRAZOLE
[French]
COMPRIMÉS COMPRENANT DU BREXPIPRAZOLE
Applicants **
SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
Inventors
SUNEL, Fatih
ATAK, Fadime Bilgehan
ATAMAN, Seval
SARP, Onder
Priority Data
2023/018024
22.12.2023
TR
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
Turkpatent
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2102 | |
| EPO | Filing, Examination, Granting | 9232 | |
| Japan | Filing, Examination, Granting | 2176 | |
| South Korea | Filing, Examination, Granting | 2115 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
20,365
Contact Us
Abstract[English]
The present invention relates to a tablet comprises brexpiprazole or a salt thereof and at least two fillers wherein the one of fillers is corn starch and brexpiprazole has a d (0.9) particle size between 1 µm and 35 µm. Further, the present invention also relates to a simple, rapid, cost effective, time-saving and industrially convenient process.[French]
La présente invention concerne un comprimé comprenant du brexpiprazole ou un sel de celui-ci et au moins deux charges, l'une des charges étant de l'amidon de maïs et du brexpiprazole ayant une taille de particule d(0,9) comprise entre 1 µm et 35 µm. En outre, la présente invention concerne également un procédé simple, rapide, économique, économe en temps et industriellement pratique.